|
2024
|
Invention
|
Agents and methods for targeted delivery of immune effector cells. The invention relates to agent... |
|
|
Invention
|
Tnf receptor 2-specific agonist fusion proteins comprising tnf homology domains and mutated fc do... |
|
|
Invention
|
Rna constructs with n-terminal degrons to enhance an immune response. The present disclosure rela... |
|
|
Invention
|
Method. nnn RNA molecule species, wherein n is an integer of at least 1, or (d) the potency of a ... |
|
|
Invention
|
Nucleic acid compositions and methods. The present invention provides nucleic acid compositions a... |
|
|
Invention
|
Antibody-drug conjugate. The present invention relates to an antibody-drug conjugate of formula (... |
|
|
Invention
|
Vhh-ch3 fusion proteins. The present invention provides improved constructs comprising immunoglob... |
|
|
Invention
|
Rna compositions for delivery of mpox antigens and related methods. The present disclosure provid... |
|
|
Invention
|
Systems and compositions comprising highly active trans-amplifying replicases. Described herein a... |
|
|
Invention
|
Rna compositions encoding antibodies targeting hiv. The present disclosure provides compositions ... |
|
|
Invention
|
Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methods. Th... |
|
|
Invention
|
Rna compositions encoding herpes simplex virus glycoprotein b antigens and uses thereof. The pres... |
|
|
Invention
|
Rna compositions encoding herpes simplex virus glycoprotein e and/or glycoprotein i antigens and ... |
|
|
Invention
|
Rna compositions targeting hiv. The present disclosure provides compositions (e.g., pharmaceutica... |
|
|
Invention
|
Ionizable thiolipids and uses thereof. The present disclosure provides a compound of formula (I):... |
|
|
Invention
|
Method of determining nucleic acid concentration in aqueous solution or dispersion. A method of d... |
|
|
Invention
|
Rna therapeutics with reduced toxicity. The disclosure provides RNA therapeutics, e.g. RNA molecu... |
|
|
Invention
|
Compositions for delivery of plasmodium antigens and related methods. The present disclosure prov... |
|
|
Invention
|
Preparation and storage of liposomal rna formulations suitable for therapy.
The present disclosu... |
|
|
Invention
|
Modular multiplatform system for mrna drug production. A drug production facility includes: a fir... |
|
|
Invention
|
Stabilization of poly(a) sequence encoding dna sequences.
The present invention relates to nucle... |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
G/S
|
Pharmaceutical preparations; vaccines. |
|
|
G/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
G/S
|
Downloadable computer software used for biotechnology research and development; downloadable comp... |
|
|
G/S
|
Database management; data management; data processing; data management services; compilation of d... |
|
|
G/S
|
Computer software; computer software comprising algorithms for the selection of pharmaceutical re... |
|
|
G/S
|
Databases; database engines; data processing software; data management software; data mining soft... |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
G/S
|
Pharmaceuticals; vaccines. |
|
|
G/S
|
Pharmaceuticals for the treatment of cancer |
|
2023
|
G/S
|
Chemical products for medical and veterinary purposes;
medical and pharmaceutical preparations. ... |
|
|
G/S
|
Chemical preparations for medical and veterinary purposes, namely, for neuroregeneration and the ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and... |
|
|
Invention
|
Methods of treatment using agents binding to epcam and cd137 in combination with pd-1 axis bindin... |
|
|
Invention
|
Antibody-drug conjugate. The present invention relates to an antibody-drug conjugate that compris... |
|
|
Invention
|
Rna compositions for delivery of incretin agents. The present disclosure provides compositions (e... |
|
|
Invention
|
Methods and compositions for localized expression of administered rna. Disclosed herein are metho... |
|
|
Invention
|
Agents and methods for targeted delivery to cells. The invention relates to agents and methods fo... |
|
|
Invention
|
Ionizable thiolipids and uses thereof. The present disclosure provides a compound of formula (I) ... |
|
|
Invention
|
Agents and methods for targeted delivery of cytokines to immune cells. The invention relates to a... |
|
|
Invention
|
Modulators of the adenosine a2a and a2b receptor. The present invention relates to the compound o... |
|
|
G/S
|
Pharmaceutical products for treatment of cancer |
|
|
Invention
|
Analysis of rna molecules using catalytic nucleic acids.
The present invention relates to a meth... |
|
2022
|
Invention
|
Chimeric antigen receptor-modified cells for the treatment of cldn6 expressing cancer.
The prese... |
|
|
Invention
|
Rna encoding peptidoglycan hydrolase and use thereof for treating bacterial infection.
The inven... |
|
|
Invention
|
Rna constructs and uses thereof.
Disclosed herein are RNA polynucleotides comprising a 5′ Cap, a... |
|
|
Invention
|
Oligosaccharide complexes and uses.
The present disclosure provides complexes comprising: i) a c... |
|
|
Invention
|
Oligosaccharide complexes and uses.
The present disclosure provides complexes comprising a catio... |
|
|
Invention
|
Oligosaccharide compounds and complexes.
The present disclosure provides a compound of formula I... |
|
|
Invention
|
Disulfide oligosaccharide compounds and complexes.
The present disclosure provides compounds, co... |
|
|
G/S
|
Personal development by means of training and further training for doctors and scientists in the ... |
|
|
Invention
|
Agents encoding cldn6 and cd3 binding elements for treating cldn6-positive cancers.
The present ... |
|
|
G/S
|
Transportable buildings of metal, namely, modular containers; transportable buildings of metal, n... |
|
|
G/S
|
Transportable buildings of metal; transportable buildings of metal for the manufacture and fillin... |
|
|
G/S
|
Transportable buildings of metal; transportable buildings of
metal for the manufacture and filli... |
|
2021
|
G/S
|
Chemicals for use in pharmaceutical industry;
Active chemical ingredients for use in manufacture... |
|
|
G/S
|
Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture ... |
